13F-HR filed by Camber Capital Management LP
Camber Capital Management LP filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-14, with 39 holding rows worth $2,909,720,000.
- Accession
- 0001654954-22-001580
- Filer
- CIK 1444043
- Filed
- 2022-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2021
A holdings report, 39 entries on the cover page, a total value of $2,909,720,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,909,720,000 with VALUE read as thousands by filing date, 13F file number 028-13745. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| VIATRIS INC COM | 92556V106 | Stock | 16,000,000 | $216,480,000 | thousands by filing date | |
| UNIVERSAL HLTH SVCS INC CL B | 913903100 | Stock | 1,650,000 | $213,939,000 | thousands by filing date | |
| Merck & Co.,Inc. | 58933Y105 | COM | 2,500,000 | $191,600,000 | thousands by filing date | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 3,800,000 | $190,380,000 | thousands by filing date | |
| WALGREENS BOOTS ALLIANCE INC | 931427108 | COM | 3,500,000 | $182,560,000 | thousands by filing date | |
| Gilead Sciences,Inc. | 375558103 | COM | 2,250,000 | $163,373,000 | thousands by filing date | |
| Merck & Co.,Inc. | 58933Y105 | COM | 2,000,000 | $153,280,000 | thousands by filing date | call |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 1,000,000 | $127,040,000 | thousands by filing date | |
| GLAXOSMITHKLINE PLC-ADR | 37733W105 | SPONSORED ADR | 2,500,000 | $110,250,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 450,000 | $98,820,000 | thousands by filing date | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 1,200,000 | $98,028,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 1,015,000 | $89,675,000 | thousands by filing date | |
| NOVARTIS AG SPONSORED ADR | 66987V109 | ADR | 1,000,000 | $87,470,000 | thousands by filing date | call |
| CHANGE HEALTHCARE INC | 15912K100 | COM | 4,000,000 | $85,520,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 575,000 | $84,347,000 | thousands by filing date | |
| BROOKDALE SR LIVING INC | 112463104 | COM | 16,000,000 | $82,560,000 | thousands by filing date | |
| MYRIAD GENETICS INC | 62855J104 | COM | 2,750,000 | $75,900,000 | thousands by filing date | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 1,500,000 | $75,150,000 | thousands by filing date | call |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 825,000 | $74,291,000 | thousands by filing date | |
| PERRIGO CO PLC SHS | G97822103 | Stock | 1,725,000 | $67,103,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 900,000 | $66,060,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 250,000 | $59,980,000 | thousands by filing date | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 3,750,000 | $50,663,000 | thousands by filing date | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 1,390,000 | $42,298,000 | thousands by filing date | |
| ORASURE TECHNOLOGIES INC | 68554V108 | COM | 4,250,000 | $36,933,000 | thousands by filing date | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 3,000,000 | $34,980,000 | thousands by filing date | |
| ALKERMES PLC | G01767105 | SHS | 1,300,000 | $30,238,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 750,000 | $29,873,000 | thousands by filing date | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 2,750,000 | $22,028,000 | thousands by filing date | |
| COLLEGIUM PHARMACEUTICAL INC | 19459J104 | COM | 1,050,000 | $19,614,000 | thousands by filing date | |
| ZYMEWORKS INC | 98985W102 | COM | 800,000 | $13,112,000 | thousands by filing date | |
| INOGEN INC | 45780L104 | COM | 200,000 | $6,800,000 | thousands by filing date | |
| TECTONIC THERAPEUTIC INC COM | 05455M100 | Stock | 1,633,333 | $6,288,000 | thousands by filing date | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 2,050,000 | $6,232,000 | thousands by filing date | |
| THERAVANCE BIOPHARMA INC | G8807B106 | COM | 500,000 | $5,525,000 | thousands by filing date | |
| NUVASIVE INC | 670704105 | COM | 100,000 | $5,248,000 | thousands by filing date | |
| GLAUKOS CORP COM | 377322102 | Stock | 75,000 | $3,333,000 | thousands by filing date | |
| INNOVAGE HLDG CORP | 45784A104 | COM | 350,000 | $1,750,000 | thousands by filing date | |
| SmileDirectClub Inc | 83192H106 | COM | 425,000 | $999,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001654954-22-001580 | this filing | 2022-02-14 | acceptance time not in the bulk data set |